Amarin Corp Plc (AMRN)

[couldbebetter]

My thought was that if AMRN found a partner the partner could first run a study to use to get the FDA approval. The partner could not only pay for the study but perhaps even an upfront fee. One poster opined that the reason AMRN would not do it is because they could not separate the use of the drug for dry-eye vs. very high triglycerides. What a shame that a very safe and effective drug will not get the attention it should for so many important indications. Thank you for all the valuable insight you provide to this forum.